Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammaplasty | 12 | 2024 | 107 | 4.520 |
Why?
|
| Mastectomy | 19 | 2023 | 243 | 3.710 |
Why?
|
| Breast Neoplasms | 22 | 2023 | 2903 | 2.720 |
Why?
|
| Breast Implants | 5 | 2023 | 23 | 2.130 |
Why?
|
| Breast Implantation | 5 | 2022 | 12 | 1.890 |
Why?
|
| Surgical Flaps | 4 | 2015 | 241 | 1.150 |
Why?
|
| Reoperation | 4 | 2020 | 597 | 0.930 |
Why?
|
| Nipples | 4 | 2020 | 37 | 0.910 |
Why?
|
| Wound Healing | 5 | 2008 | 344 | 0.840 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2020 | 166 | 0.830 |
Why?
|
| Postoperative Complications | 7 | 2023 | 2207 | 0.780 |
Why?
|
| Unilateral Breast Neoplasms | 1 | 2020 | 5 | 0.770 |
Why?
|
| Free Tissue Flaps | 1 | 2018 | 49 | 0.630 |
Why?
|
| Mastectomy, Subcutaneous | 1 | 2016 | 8 | 0.580 |
Why?
|
| Surgical Wound Infection | 2 | 2015 | 184 | 0.570 |
Why?
|
| Prostheses and Implants | 2 | 2008 | 121 | 0.560 |
Why?
|
| Patient Satisfaction | 3 | 2016 | 455 | 0.540 |
Why?
|
| Age Factors | 3 | 2015 | 1851 | 0.530 |
Why?
|
| Prophylactic Surgical Procedures | 1 | 2015 | 7 | 0.530 |
Why?
|
| Quality of Life | 4 | 2020 | 1585 | 0.510 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2015 | 157 | 0.500 |
Why?
|
| Female | 28 | 2023 | 44533 | 0.500 |
Why?
|
| Cicatrix, Hypertrophic | 3 | 2008 | 8 | 0.490 |
Why?
|
| Mastectomy, Segmental | 3 | 2021 | 93 | 0.490 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 238 | 0.480 |
Why?
|
| Facial Paralysis | 1 | 2013 | 17 | 0.460 |
Why?
|
| Prophylactic Mastectomy | 3 | 2018 | 13 | 0.450 |
Why?
|
| Venous Thromboembolism | 1 | 2015 | 153 | 0.430 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2012 | 113 | 0.410 |
Why?
|
| Humans | 31 | 2024 | 86644 | 0.370 |
Why?
|
| Retrospective Studies | 9 | 2023 | 8489 | 0.370 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 449 | 0.360 |
Why?
|
| Adult | 15 | 2023 | 25648 | 0.360 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2008 | 14 | 0.340 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2008 | 69 | 0.330 |
Why?
|
| Ultrasonography, Doppler | 1 | 2008 | 80 | 0.310 |
Why?
|
| Healthcare Disparities | 1 | 2012 | 371 | 0.310 |
Why?
|
| Macrophage-1 Antigen | 1 | 2007 | 17 | 0.310 |
Why?
|
| Databases, Factual | 3 | 2016 | 814 | 0.310 |
Why?
|
| Ultrasonography, Interventional | 1 | 2008 | 121 | 0.310 |
Why?
|
| Mononeuropathies | 1 | 2007 | 8 | 0.300 |
Why?
|
| Middle Aged | 15 | 2021 | 25028 | 0.290 |
Why?
|
| Arthroplasty, Replacement | 1 | 2007 | 37 | 0.290 |
Why?
|
| Pressure Ulcer | 1 | 2007 | 42 | 0.290 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2005 | 5 | 0.280 |
Why?
|
| Monocytes | 1 | 2007 | 214 | 0.270 |
Why?
|
| Suture Techniques | 2 | 2009 | 135 | 0.270 |
Why?
|
| Ilium | 1 | 2005 | 18 | 0.270 |
Why?
|
| Reperfusion Injury | 1 | 2007 | 131 | 0.270 |
Why?
|
| Shoulder Joint | 1 | 2007 | 90 | 0.270 |
Why?
|
| Abdominal Wall | 1 | 2005 | 30 | 0.270 |
Why?
|
| Surgical Mesh | 1 | 2005 | 116 | 0.250 |
Why?
|
| Ischemia | 2 | 2004 | 243 | 0.250 |
Why?
|
| Up-Regulation | 1 | 2007 | 712 | 0.240 |
Why?
|
| Breast Cancer Lymphedema | 1 | 2023 | 4 | 0.240 |
Why?
|
| Tissue Expansion Devices | 1 | 2023 | 8 | 0.240 |
Why?
|
| Aged | 10 | 2021 | 18415 | 0.230 |
Why?
|
| RNA, Messenger | 2 | 2008 | 1981 | 0.230 |
Why?
|
| Bone Neoplasms | 1 | 2005 | 322 | 0.220 |
Why?
|
| Skin Ulcer | 1 | 2003 | 25 | 0.220 |
Why?
|
| Lymphedema | 1 | 2023 | 77 | 0.220 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2022 | 71 | 0.210 |
Why?
|
| Socioeconomic Factors | 2 | 2016 | 567 | 0.210 |
Why?
|
| Acellular Dermis | 1 | 2021 | 4 | 0.210 |
Why?
|
| Length of Stay | 2 | 2015 | 702 | 0.210 |
Why?
|
| Tissue Expansion | 1 | 2021 | 19 | 0.200 |
Why?
|
| United States | 6 | 2018 | 6672 | 0.200 |
Why?
|
| Patient Discharge | 1 | 2023 | 300 | 0.190 |
Why?
|
| Organ Sparing Treatments | 1 | 2020 | 38 | 0.180 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 6509 | 0.180 |
Why?
|
| Bone Transplantation | 1 | 2018 | 64 | 0.160 |
Why?
|
| Rabbits | 4 | 2008 | 636 | 0.160 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1920 | 0.160 |
Why?
|
| Skin Transplantation | 1 | 2018 | 172 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 746 | 0.150 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 204 | 0.150 |
Why?
|
| Surveys and Questionnaires | 2 | 2016 | 2501 | 0.150 |
Why?
|
| Prospective Studies | 3 | 2021 | 4214 | 0.150 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1019 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2020 | 1313 | 0.140 |
Why?
|
| Esthetics | 1 | 2016 | 44 | 0.140 |
Why?
|
| Population Surveillance | 1 | 2016 | 219 | 0.130 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 160 | 0.130 |
Why?
|
| Graft Survival | 1 | 2018 | 884 | 0.130 |
Why?
|
| Prosthesis Failure | 1 | 2015 | 111 | 0.130 |
Why?
|
| Carcinoma in Situ | 1 | 2015 | 53 | 0.120 |
Why?
|
| Blood Transfusion | 1 | 2015 | 157 | 0.120 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1805 | 0.120 |
Why?
|
| Community Health Planning | 2 | 2024 | 21 | 0.120 |
Why?
|
| Transplantation, Autologous | 1 | 2015 | 331 | 0.120 |
Why?
|
| Time-to-Treatment | 1 | 2014 | 98 | 0.120 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 351 | 0.110 |
Why?
|
| Genes, BRCA2 | 1 | 2014 | 160 | 0.110 |
Why?
|
| Risk | 1 | 2015 | 674 | 0.110 |
Why?
|
| Genes, BRCA1 | 1 | 2014 | 192 | 0.110 |
Why?
|
| Face | 1 | 2013 | 114 | 0.110 |
Why?
|
| Patient Selection | 1 | 2016 | 685 | 0.100 |
Why?
|
| Surgeons | 1 | 2016 | 238 | 0.100 |
Why?
|
| Feasibility Studies | 2 | 2024 | 751 | 0.100 |
Why?
|
| Health Care Surveys | 1 | 2012 | 278 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 508 | 0.100 |
Why?
|
| Sepsis | 1 | 2015 | 306 | 0.100 |
Why?
|
| Comorbidity | 1 | 2015 | 943 | 0.100 |
Why?
|
| Granulation Tissue | 2 | 2007 | 15 | 0.090 |
Why?
|
| Rats | 3 | 2007 | 3990 | 0.090 |
Why?
|
| Animals | 7 | 2008 | 26582 | 0.090 |
Why?
|
| Time Factors | 4 | 2016 | 5210 | 0.080 |
Why?
|
| Young Adult | 2 | 2021 | 5976 | 0.080 |
Why?
|
| Esophagus | 1 | 2009 | 102 | 0.080 |
Why?
|
| Logistic Models | 1 | 2012 | 1186 | 0.080 |
Why?
|
| Esophagectomy | 1 | 2009 | 84 | 0.080 |
Why?
|
| Ultraviolet Therapy | 1 | 2008 | 15 | 0.080 |
Why?
|
| False Negative Reactions | 1 | 2008 | 63 | 0.080 |
Why?
|
| Veins | 1 | 2008 | 94 | 0.080 |
Why?
|
| Immunochemistry | 1 | 2007 | 16 | 0.080 |
Why?
|
| Smad Proteins | 1 | 2007 | 39 | 0.080 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2007 | 40 | 0.080 |
Why?
|
| Heme Oxygenase-1 | 1 | 2007 | 19 | 0.080 |
Why?
|
| Child | 1 | 2018 | 6927 | 0.070 |
Why?
|
| Wounds, Penetrating | 1 | 2007 | 46 | 0.070 |
Why?
|
| Humerus | 1 | 2007 | 31 | 0.070 |
Why?
|
| Debridement | 1 | 2007 | 56 | 0.070 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2007 | 46 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2007 | 42 | 0.070 |
Why?
|
| Rotator Cuff | 1 | 2007 | 44 | 0.070 |
Why?
|
| Male | 5 | 2018 | 40966 | 0.070 |
Why?
|
| Esophageal Neoplasms | 1 | 2009 | 321 | 0.070 |
Why?
|
| Monitoring, Physiologic | 1 | 2008 | 268 | 0.070 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2007 | 113 | 0.070 |
Why?
|
| Urinary Fistula | 1 | 2006 | 7 | 0.070 |
Why?
|
| Urethral Stricture | 1 | 2006 | 13 | 0.070 |
Why?
|
| Urethral Diseases | 1 | 2006 | 15 | 0.070 |
Why?
|
| Syndrome | 1 | 2007 | 446 | 0.070 |
Why?
|
| Rectal Fistula | 1 | 2006 | 18 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2008 | 2232 | 0.070 |
Why?
|
| Mouth Mucosa | 1 | 2006 | 67 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 301 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 407 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 927 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 2438 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 1219 | 0.060 |
Why?
|
| Macrophages | 1 | 2007 | 554 | 0.060 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2023 | 68 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2007 | 971 | 0.060 |
Why?
|
| Axilla | 1 | 2023 | 99 | 0.060 |
Why?
|
| Necrosis | 1 | 2023 | 204 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2007 | 1924 | 0.050 |
Why?
|
| Lymph Node Excision | 1 | 2023 | 217 | 0.050 |
Why?
|
| Models, Animal | 1 | 2003 | 263 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 3640 | 0.050 |
Why?
|
| Skin | 1 | 2004 | 554 | 0.050 |
Why?
|
| Contraindications, Procedure | 1 | 2020 | 5 | 0.050 |
Why?
|
| Apoptosis | 1 | 2007 | 1683 | 0.050 |
Why?
|
| Collagen | 1 | 2021 | 269 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2023 | 7993 | 0.040 |
Why?
|
| Aging | 1 | 2004 | 691 | 0.040 |
Why?
|
| Research Design | 1 | 2003 | 594 | 0.040 |
Why?
|
| Fees and Charges | 1 | 2018 | 14 | 0.040 |
Why?
|
| Hospital Charges | 1 | 2018 | 29 | 0.040 |
Why?
|
| Propensity Score | 1 | 2018 | 136 | 0.040 |
Why?
|
| Ear | 2 | 2008 | 18 | 0.040 |
Why?
|
| Emotions | 1 | 2021 | 341 | 0.040 |
Why?
|
| Incidence | 1 | 2021 | 1577 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1621 | 0.030 |
Why?
|
| Self Report | 1 | 2016 | 288 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 839 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2014 | 160 | 0.030 |
Why?
|
| Mice | 1 | 2007 | 11352 | 0.030 |
Why?
|
| Heterozygote | 1 | 2014 | 365 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 357 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2014 | 328 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2018 | 2767 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 394 | 0.020 |
Why?
|
| Physicians | 1 | 2018 | 673 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 1939 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2009 | 83 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 8981 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2009 | 267 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 3679 | 0.020 |
Why?
|
| Fluorescein | 1 | 2004 | 16 | 0.020 |
Why?
|
| Urologic Surgical Procedures | 1 | 2006 | 146 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2004 | 156 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 3968 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 1284 | 0.010 |
Why?
|
| Contrast Media | 1 | 2004 | 1078 | 0.010 |
Why?
|